Effect of Omega-3 Fatty Acids on Plasma Level of 8-Isoprostane in Kidney Transplant Patients Mohammad Ramezani, PharmD, PhD, Fatemeh Nazemian, MD, Jamal Shamsara, PharmD, PhD, Reza Koohrokhi, PharmD, Amir Hooshang Mohammadpour, PharmD, PhD Journal of Renal Nutrition Volume 21, Issue 2, Pages 196-199 (March 2011) DOI: 10.1053/j.jrn.2010.06.023 Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 Comparison between changes in the 8-isoprostane levels between drug and placebo groups after 3 and 6 months of treatment with omega-3 fatty acids or placebo, respectively (Mean ± SE). Journal of Renal Nutrition 2011 21, 196-199DOI: (10.1053/j.jrn.2010.06.023) Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions
Figure 2 Comparison of total cholesterol levels between the 2 groups after 6 months of treatment. Mean ± SE (mg/dL) (P < .05). Journal of Renal Nutrition 2011 21, 196-199DOI: (10.1053/j.jrn.2010.06.023) Copyright © 2011 National Kidney Foundation, Inc. Terms and Conditions